Back to Selection     Print       Date : 30 Nov 2025
Fund Summary
Nippon India Pharma Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 05-Jun-04
Corpus(Cr.) 8459.0 Latest NAV 481.8247 As on 29-01-2026
Equity(%) 99.47 52 Week High 536.807
Debt(%) 0.53 52 Week Low 451.81
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.81
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Sailesh Raj Bhan
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 40.20%
Top 10 Holdings 58.38%
Top 25 Holdings 90.27%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 75.31
Healthcare 20.69
Retail 3.47
Cash 0.53
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.49
PE Ratio 0.00
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 13.55
Lupin Limited 7.59
DIVI LABORATORIES LTD. 6.90
Cipla Limited 6.33
Dr Reddys Laboratories Limited 5.83
Apollo Hospitals Enterprise Limited 5.63
Medplus Health Services Limited 3.47
VIJAYA DIAGNOSTIC CENTRE LIMITED 3.41
Ajanta Pharma Limited 2.90
Glaxosmithkline Pharma Ltd 2.77
Gland Pharma Limited 2.75
Sai Life Sciences Limited 2.67
Thyrocare Technologies Limited 2.57
Aurobindo Pharma Limited 2.47
Abbott India Limited 2.44
Dr Lal Path Labs Ltd 2.20
Alkem Laboratories Limited 2.18
Narayana Hrudalaya Ltd 2.12
J B Chemicals and Pharma Ltd 2.09
Mankind Pharma Limited 2.02
Biocon Limited 1.99
IPCA Laboratories Limited 1.93
Pfizer Limited 1.87
SURAKSHA DIAGNOSTIC LTD 1.35
Emcure Pharmaceuticals Limited 1.24

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
-4.58% -6.61% -10.03% 1.58%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
-1.95% -2.33% 2.82% 11.06%
 
Scheme Benchmark [NSE - Nifty Healthcare TRI]
-5.17% -7.63% -8.31% 2.09%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
8.39% 20.15% 14.60% 13.04%
 
 
9.44% 14.31% 14.62% 14.28%
 
 
11.76% 21.05% 14.74% 8.72%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
Nippon India Pharma Fund (G) 15.24% 1.0719 10.0962% 45.1962 0.1508
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
Nippon India Pharma Fund (G) 11.3921% 0.0002 0.2896 14.1047 0.6713
 
Back to Selection